Fujian Cosunter Pharmaceutical Co Ltd Financial Flexibility Index
Fujian Cosunter Pharmaceutical Co Ltd financial flexibility index. Fujian Cosunter Pharmaceutical Co Ltd (300436) has a Financial Flexibility Index of -0.01x as of September 2025. Free cash flow of CN¥-12.39 Million (operating CF CN¥-25.74 Million minus capex CN¥13.35 Million) represents 0% of total liabilities (CN¥1.05 Billion). Explore 300436 capex reinvestment rate to see what proportion of operating cash flow is directed to capital expenditures.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Financial Flexibility Index of Fujian Cosunter Pharmaceutical Co Ltd (2011–2025)
Financial flexibility index of Fujian Cosunter Pharmaceutical Co Ltd from 2011 to 2025. Historical Financial Flexibility Index trend for Fujian Cosunter Pharmaceutical Co Ltd across 15 annual periods. Check cash flow reinvestment rate of Fujian Cosunter Pharmaceutical Co Ltd to assess the company's total reinvestment commitment from operating cash flow.
Fujian Cosunter Pharmaceutical Co Ltd Financial Flexibility Index by Year (2011–2025)
Fujian Cosunter Pharmaceutical Co Ltd financial flexibility index by year from 2011 to 2025. Year-by-year free cash flow to debt coverage for Fujian Cosunter Pharmaceutical Co Ltd. For the full cash flow conversion analysis, see 300436 cash flow conversion.
| Year | Flexibility Index | Free Cash Flow (CNY) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.02x | CN¥24.49 Million | CN¥-35.05 Million | CN¥1.05 Billion | ▼ -72.4% |
| 2024 | 0.08x | CN¥87.70 Million | CN¥20.71 Million | CN¥1.04 Billion | ▲ +230.2% |
| 2023 | 0.03x | CN¥26.64 Million | CN¥-174.60 Million | CN¥1.05 Billion | ▼ -82.0% |
| 2022 | 0.14x | CN¥76.28 Million | CN¥-119.68 Million | CN¥539.22 Million | ▼ -64.2% |
| 2021 | 0.39x | CN¥156.64 Million | CN¥-17.76 Million | CN¥396.92 Million | ▲ +138.9% |
| 2020 | 0.17x | CN¥70.05 Million | CN¥15.60 Million | CN¥424.10 Million | ▼ -47.7% |
| 2019 | 0.32x | CN¥101.80 Million | CN¥33.99 Million | CN¥322.51 Million | ▼ -61.6% |
| 2018 | 0.82x | CN¥240.21 Million | CN¥10.94 Million | CN¥292.33 Million | ▲ +41.6% |
| 2017 | 0.58x | CN¥107.04 Million | CN¥71.47 Million | CN¥184.42 Million | ▼ -44.9% |
| 2016 | 1.05x | CN¥156.34 Million | CN¥73.84 Million | CN¥148.30 Million | ▼ -40.2% |
| 2015 | 1.76x | CN¥143.59 Million | CN¥111.63 Million | CN¥81.50 Million | ▼ -14.2% |
| 2014 | 2.05x | CN¥138.08 Million | CN¥107.04 Million | CN¥67.24 Million | ▲ +23.1% |
| 2013 | 1.67x | CN¥90.81 Million | CN¥66.20 Million | CN¥54.42 Million | ▼ -0.1% |
| 2012 | 1.67x | CN¥68.21 Million | CN¥41.97 Million | CN¥40.82 Million | ▲ +0.2% |
| 2011 | 1.67x | CN¥73.12 Million | CN¥53.15 Million | CN¥43.86 Million | — |